Search Within

Tarun Kewalramani

Refine Results
Formats
  1. Meeting Abstract (38)
  2. Journal Article (24)
  3. Book Section (1)
Groups
  1. Hematologic Oncology, Division of (50)
  2. Center for Hematologic Malignancies (47)
  3. Leukemia Disease Management Team (45)
  4. Myeloma Disease Management Team (44)
  5. Lymphoma Disease Management Team (41)
  6. Hematologic Oncology Disease Management Team (40)

More Groups

People
  1. Stephen Nimer (40)
  2. Craig Moskowitz (33)
  3. Andrew Zelenetz (29)
  4. Joachim Yahalom (23)
  5. Julie Feldstein (16)
  6. Raymond Comenzo (16)

More People

Years
  1. 2010 (3)
  2. 2009 (3)
  3. 2008 (6)
  4. 2007 (8)
  5. 2006 (7)
  6. 2005 (7)

More Years

Publications
  1. Blood (35)
  2. Bone Marrow Transplantation (5)
  3. British Journal of Haematology (5)
  4. Journal of Clinical Oncology (4)
  5. Biology of Blood and Marrow Transplantation (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Hematology (35)
  2. Nature Publishing Group (6)
  3. John Wiley & Sons (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (4)
  6. Oxford University Press (3)

More Publishers

Results (63)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
    Blood (2002)

    Fulltext@MSK | Save
  • Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S.; Qin, J.; Malhotra, S.; Yahalom, J.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • Gemicitabine/vinorelbine - A well tolerated and effective regimen for patients with relapsed/refractory Hodgkin's disease (RD) who fail autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Hamlin, P. A.; Kewalramani, T.; Schaindlin, P.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • Autologous transplantation (ASCT) with total body irradiation (TBI) based conditioning appears superior to chemotherapy only (Non-TBI) conditioning for patients with relapsed or primary refractory chemosensitive (CS) diffuse large B-cell lymphoma (DLBCL) who have no extranodal sits (ENS) of disease (dz)
    Meeting Abstract

    Kewalramani, T.; Moskowitz, C. H.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Results of autologous stem cell transplantation (SCT) following stem cell mobilization with melphalan in myeloma patients
    Meeting Abstract

    Comenzo, R. L.; Costello, S.; Reich, L.; Drake, L.; Zhou, P.; Martinez, C.; Klimek, V.; Kewalramani, T.; Osman, K.; Dhodapkar, M.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Phase II study of accelerated fractionation involved field radiotherapy (IFRT), total body irradiation (TBI), ifosfamide and continuous infusion etoposide with autologous stem cell transplantation (ASCT) in the treatment of patients with relapsed and primary refractory aggressive non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Kewalramani, T.; Malhotra, S.; Nimer, S. D.
    Blood (2001)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • Blood stem cell mobilization with intravenous melphalan in patients with multiple myeloma
    Meeting Abstract

    Osman, K.; Drake, L.; Costello, S.; Reich, L.; Wuest, D.; Klimek, V.; Kewalramani, T.; Gucciardo, A.; Fleisher, M.; Martinez, C.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • Upfront transplantation for poor-risk aggressive non-Hodgkin lymphoma and Hodgkin's disease: Who benefits?
    Journal Article

    Kewalramani, T.; Moskowitz, C. H.
    Current Oncology Reports (2001)

    Fulltext@MSK | Save
  • Outcome of adult patients (pts) with chemosensitive (CS) relapsed or primary refractory Hodgkin's disease (HD) or aggressive NHL (NHL) after failure of autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Malhotra, S.; Qin, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2000)

    Fulltext@MSK | Save